Cerenome (PSTV) Non Operating Investment Income (2013)
Plus Therapeutics (PSTV) posted quarterly Non Operating Investment Income of $4.9 million for Q2 2013.
Cerenome (PSTV) Non Operating Investment Income (2013) Analysis & Trends
Plus Therapeutics (PSTV) has reported Non Operating Investment Income for 1 consecutive years, with $4.9 million the latest figure, recorded in Q2 2013.
- In Q2 2013, Non Operating Investment Income changed N/A year-over-year to $4.9 million; the TTM figure through Jun 2014 stood at $4.9 million (changed 0.0% YoY), while the FY2013 annual figure was $4.9 million, changed N/A from the prior year.
- Non Operating Investment Income was little changed at $4.9 million in Q2 2013 per PSTV's latest filing.
- Across five years, Non Operating Investment Income topped out at $4.9 million in Q2 2013 and bottomed at $4.9 million in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 4.89 Mn |
| Jun 30, 2013 | 4.89 Mn |